Diabetes drugs being used for weight loss have gained attention as potential allies in the battle against obesity. With a staggering 42% of adults grappling with obesity, the GLP-1 receptor agonists have emerged as a promising trend. In addition, adults with diabetes incur medical expenditures of $16,750 per year on average.
How can employers cope with these costs and enhance employee health? Are GLP-1 drugs helpful or just a lot of hype?
Discover benefits and trade-offs of covering GLP-1 drugs for weight loss and smart strategies for diabetes management.
Host:
Adrienne LaBorwit, Chief Strategy Officer, True Rx Health Strategists
Guest Panelists:
John Dieser, Terra Health Coaching
John Dieser is President and CEO of Terra Health Coaching, which offers certified health coaches to reduce chronic disease and serve as a bridge between doctors and home. John holds an MBA from Villanova and is a certified health coach who studied at the Institute for Integrative Nutrition.
Chelsea Durnil, PharmD, BCACP, True Rx Health Strategists
Chelsea Durnil, PharmD, BCACP, is a Clinical Innovation Pharmacist and operates OnTrack Diabetes Management at True Rx. She previously worked as an Ambulatory Care Pharmacist at Indiana State University. She earned her Doctor of Pharmacy degree at Purdue University.
Eric Barker, RPh, Chief Growth Officer, Ture Rx Health Strategists
Eric Barker, RPh, is Chief Growth Officer for True Rx Health Strategists. His expertise in pharmacy benefits strategy and solutions is informed by a career in clinical pharmacy and pharmacy services management.
Eric regularly speaks at national and regional conferences on various health care and benefits topics. In addition, he has been a preceptor for pharmacy students from the University of Wisconsin, Purdue University, and Butler University, while also teaching graduate pharmacology for nurse practitioners at the University of Indianapolis. He is a graduate of the University of Toledo College of Pharmacy.
